Post-Finasteride Syndrome or Pre-Existing Vulnerability? Rethinking Patient Selection

The article discusses post-finasteride syndrome (PFS), a condition with persistent symptoms reported by some after stopping finasteride, a drug for androgenetic alopecia. It suggests that PFS may often be linked to pre-existing psychological vulnerabilities rather than the drug itself, highlighting the role of nocebo responses where negative expectations cause symptoms. The author emphasizes the importance of addressing psychological factors and misinformation when prescribing finasteride. A proposed solution is a pre-treatment psychological screening tool to identify individuals at risk of adverse outcomes, which could improve patient outcomes and reduce treatment discontinuation. The article calls for further research to develop standardized screening tools and integrate psychological assessments into finasteride prescribing practices.